Dermacyd PH_DETINBACK Tangerine Mix (Lactic Acid) - Safety.

Phase 3

Completed

• Conditions: Hygiene
• Interventions: Drug: Lactic Acid

• Registration Number: NCT00783939
• Lead Sponsor: Sanofi

Brief Summary

The purpose of this study is to prove the safety in normal conditions of useof the product Dermacyd PH_DETINBACK Tangerine Mix (Lactic Acid).

Detailed Description

Not available

Study Timeline

• Study Start: 2008-09
• Primary Completion: 2008-09
• Study First Submitted: 2008-10-31
• Study First Submitted QC: 2008-10-31
• Study First Posted: 2008-11-02
• Status Verified: 2009-03
• Last Update Submitted: 2009-03-05
• Last Update Posted: 2009-03-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 31

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
1	Lactic Acid	Lactic Acid (Dermacyd PH_DETINBACK Tangerine Mix)

Primary Outcome Measures

Name	Time	Method
The absence of irritation and the good acceptability will be evaluated using one specific scale which describes the intensity of the reaction.	From the treatment start to the end of the study

Trial Locations

Locations (1)

Sanofi-Aventis Administrative Office; 🇧🇷 Sao Paulo, Brazil